Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels

Background As the result of the high prevalence of comorbidities and conventional risk factors among patients with type 2 diabetes (T2DM), most patients belong to the highest cardiovascular disease risk category, and have a target low-density lipoprotein cholesterol (LDL-C) of

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical lipidology 2012-09, Vol.6 (5), p.434-442
Hauptverfasser:	Querton, Laurent, MD, Buysschaert, Martin, MD, PhD, Hermans, Michel P., MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Apolipoprotein B100 Apolipoproteins B - blood Atherogenic dyslipidemia Cardiovascular Cardiovascular Diseases - complications Cholesterol, HDL - blood Cholesterol, LDL - blood Diabetes Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypertriglyceridemia - complications LDL-C Male Non-HDL-C Reference Values Risk Statins Treatment Outcome Triglycerides
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background As the result of the high prevalence of comorbidities and conventional risk factors among patients with type 2 diabetes (T2DM), most patients belong to the highest cardiovascular disease risk category, and have a target low-density lipoprotein cholesterol (LDL-C) of
ISSN:	1933-2874 1876-4789
DOI:	10.1016/j.jacl.2012.04.002